Pharma manufacturing news in brief
April 17, 2012Manufacturing and Production Intertek and Pharmatek Labs, Jubilant, Penn Pharma
Raw material issues disrupting pharma production in Pakistan, Jubilant opens a new plant in Gujarat, plus updates from Penn Pharma, …
Lilly’s John Lechleiter elected as PhRMA Board chairman
April 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly
John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …
Pharma baffled by NHS’ moving target
April 17, 2012Sales and Marketing CCG, Cameron, Lansley, NHS, reforms
The reforms of England’s health service have now finally been passed into law, but the pharma industry will struggle to …
Lonza lined up as backup manufacturer for Agennix’s talactoferrin
April 16, 2012Manufacturing and Production Agennix, DSM Pharmaceutical, Lona
Agennix has taken a ‘belt-and-braces’ approach to manufacturing its lead pipeline product, signing a new deal with Lonza a month …
J&J fined after ‘lying to patients for profit’
April 16, 2012Medical Communications, Sales and Marketing J&J, JJ, Janssen, Risperdal, US
A US judge has slapped a $1.19 billion fine on Johnson & Johnson after it was found to be downplaying …
South Africa makes pharma a ‘designated’ industry
April 16, 2012Manufacturing and Production DTI, Rob Davies, South Africa
The government of South Africa has said it will only buy certain pharmaceutical products that are manufactured in domestic facilities, …
New health boards met with cautious optimism
April 16, 2012Sales and Marketing NHS, king's fund
The new joined-up health and wellbeing boards have been well received by The King’s Fund, but the think tank warns …
Merck signs deal with venture capitalists
April 16, 2012Research and Development, Sales and Marketing Flagship Ventures, Merck
Merck has entered a deal with a US venture capital firm specialising in life sciences to help build the manufacturer’s …
Aesica approval sets up further US expansion
April 16, 2012Manufacturing and Production Aesica, FDA
UK contract manufacturer and ingredient supplier Aesica says its manufacturing facility at Queenborough has successfully passed its first FDA inspection …
Diabetes UK launches new peer support service
April 16, 2012Diabetes UK, diabetes, peer support
Diabetes UK has launched a new support service that puts people with diabetes in touch with others who have the …
Senior team moves at ROCK medical communications
April 16, 2012Business Services, Medical Communications, Sales and Marketing Rock Medical Communications
ROCK medical communications has appointed Eric Hansen as director and promoted Clare Pressney to associate director. Most recently Hansen spent …
MSI appoints new partner
April 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, Sanofi, appointment
Pharma consultancy firm MSI has announced the appointment of a new partner. Steve Mather takes up this senior position with …
UK government invests in new radiotherapy treatment
April 16, 2012Sales and Marketing Cancer, Photon beam therapy, Proton beam therapy, prostate cancer, radiotherapy
The government is to invest £250 million in a cutting-edge radiotherapy treatment that should benefit 1,500 cancer patients in the …
Cloud computing ‘eagerly anticipated’ by healthcare
April 16, 2012Medical Communications, Sales and Marketing Cloud Computing, digital, healthcare
The use of cloud computing in healthcare is expected to grow significantly in the coming years, but developed countries may …
Takeda to buy gout specialist URL Pharma for $800m
April 16, 2012Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout
Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid. …
Access to new cancer drugs limited in Brazil and Mexico
April 13, 2012Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets
Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …
Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
UCB launches ‘Parkinson’s Well-Being Map’
April 13, 2012Medical Communications Parkinson's disease, UCB
UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …
Innovating in China’s pharma market
April 12, 2012Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets
The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …
ViiV Healthcare appoints Just:: Health PR
April 12, 2012Medical Communications, Sales and Marketing HIV/AIDS, Just::, PR, ViiV
ViiV Healthcare has appointed Just:: Health PR to work on an integrated political and public relations initiative that will engage …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
